Goldman Sachs Group Inc Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Goldman Sachs Group Inc

  • $706 Billion
  • Q2 2025

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

May 14, 2024
BUY
$14.85 - $19.04 $26 Million - $33.4 Million
1,752,000 New
1,752,000 $28.7 Million
Q4 2022

Feb 13, 2023
BUY
$14.85 - $19.04 $26 Million - $33.4 Million
1,752,000 New
1,752,000 $28.7 Million

Others Institutions Holding DCPH

# of Institutions
5
Shares Held
212K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email